tetano
Editor, Senior Moderator
Arq Bras Cardiol. 2009 Dec;93(6):e91-2, e104-6.
Influenza A (H1N1) pneumonia in an immunossupressed patient after heart transplantation.
[Article in English, Portuguese]
Bacal F, Seguro LF, Ogawa T, Mangini S, Fiorelli A, Bocchi E.
Instituto do Cora??o, Faculdade de Medicina, Universidade de S?o Paulo, S?o Paulo, SP, Brasil. fbacal@uol.com.br
Abstract
The role of the immune response during Influenza H1N1 virus infection is not yet fully established, but it is believed that it decisively participates in the severity of the disease as well as in the development of acute respiratory distress syndrome. The role of immunomodulating therapies in the control of viral infections is not a consensus either, and data from the literature defining the indications for their use are lacking. The present report is, to our knowledge, the first on a heart transplant patient who developed H1N1 virus infection and had a favorable outcome, thus generating discussion on the real role of immunosuppressive therapy as a risk factor for the severe form of the disease.
PMID: 20379621 [PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/20379621
Influenza A (H1N1) pneumonia in an immunossupressed patient after heart transplantation.
[Article in English, Portuguese]
Bacal F, Seguro LF, Ogawa T, Mangini S, Fiorelli A, Bocchi E.
Instituto do Cora??o, Faculdade de Medicina, Universidade de S?o Paulo, S?o Paulo, SP, Brasil. fbacal@uol.com.br
Abstract
The role of the immune response during Influenza H1N1 virus infection is not yet fully established, but it is believed that it decisively participates in the severity of the disease as well as in the development of acute respiratory distress syndrome. The role of immunomodulating therapies in the control of viral infections is not a consensus either, and data from the literature defining the indications for their use are lacking. The present report is, to our knowledge, the first on a heart transplant patient who developed H1N1 virus infection and had a favorable outcome, thus generating discussion on the real role of immunosuppressive therapy as a risk factor for the severe form of the disease.
PMID: 20379621 [PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/20379621